Critical Periods of Exercise

Status Completed

Clinical Trial Summary

Early childhood (~3-7 years of age) is an important window for determining body composition trajectory and may be a critical period for the development of tissue partitioning patterns that influence obesity risk. As adiposity accelerates during this critical period, deposition/ preservation of fat stores may be sustained at the 'expense' of other tissues; i.e. energy homeostasis may be inherently biased toward fat gain. The type and amount of tissue mass accrued in early childhood has implications for metabolic profile, glucose/insulin homeostasis, hormone profile and resting energy expenditure.

The interplay between fat and bone deposition represents a physiologic trait enabling the body to choose between shuttling 'energy' towards accrual of a particular tissue. Plausibly the phenotype underlying obesity and diabetes risk may be determined by the differentiation of cell type (adipocyte, osteocyte, etc.) during this early stage of growth and development. In vitro studies demonstrate transdifferentiation under the influence of specific external stimuli, which can switch phenotypes toward other cell lineages. Further, rodent models have demonstrated that exposure to stimuli (exercise) early in life may prevent excess fat mass accrual in adulthood, even when the stimulus is later removed (animals are no longer exercising). Children's early experiences (engagement in physical activity vs. sedentary behavior) may 'environmentally induce' alterations in body composition and predispose individuals to obesity throughout life.

Aim 1. To examine the associations between body composition via DXA and objectively-measured physical activity/inactivity.

1. Hypothesis 1.1: There is a positive association between physical activity and bone mass.

2. Hypothesis 1.2: There is a positive association between sedentary behavior and total fat mass.

Aim2. To examine the associations between adipose tissue distribution via MRI and objectively-measured physical activity/inactivity.

3. Hypothesis 2.1: There is an inverse association between physical activity and bone marrow adipose tissue.

4. Hypothesis 2.2: There is a positive association between sedentary behavior and bone marrow adipose tissue.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Metabolism

Clinical Trial Details

NCT number	NCT01041820
Study type	Interventional
Source	University of Alabama at Birmingham
Contact
Status	Completed
Phase	N/A
Start date	December 2009
Completion date	June 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00070577` - Influence of Age and Sex on Alcohol Metabolism and Acute Responses	N/A
Active, not recruiting	`NCT05488574` - Effects of Novel Breathing Behavior Modification Yoga Positioning Integrated Program on Weight Loss	N/A
Recruiting	`NCT05582824` - Lactate Metabolism in the Hypoperfused Critically Ill
Recruiting	`NCT05443347` - Activity, Adiposity, and Appetite in Adolescents 2 Intervention	N/A
Completed	`NCT05020808` - The Effect of a Plant Protein Isolate on Muscle Protein Synthesis in Humans at Rest and After Resistance Exercise	N/A
Recruiting	`NCT06082726` - The Systemic Concentration of Short-Chain Fatty Acids After Delivery in the Small and Large Intestine of Healthy Volunteers	N/A
Completed	`NCT04144426` - Meal Schedule Effects on Circadian Energy Balance in Adults	N/A
Completed	`NCT03424395` - Personalized Dietary Program and Markers of Wellness	N/A
Completed	`NCT02441296` - Carbohydrate and Metabolism: a Pilot Study	N/A
Completed	`NCT00176085` - Pharmacokinetics of THCCOOH and Its Acyl-glucuronide After Intravenous Administration of THCCOOH	Phase 1
Completed	`NCT00245986` - Effect of Genetics on Metabolism of Efavirenz	Phase 4
Completed	`NCT04025346` - To Evaluate the Efficacy of Capsimax on Metabolic Rate	N/A
Completed	`NCT04078646` - Influence of Proteins on the Bioavailability of Carotenoids	N/A
Active, not recruiting	`NCT06033898` - Inactivity Duration on Lipid Metabolism	N/A
Active, not recruiting	`NCT06250270` - Effects of Casein Protein on Metabolism When Taken Prior to Sleep and in the Morning	Early Phase 1
Completed	`NCT06285578` - Effects of Probiotic and HIIT in Obese Women	N/A
Completed	`NCT04255368` - Choline Source, Gut Microbiota and Trimethylamine-N-oxide Response	N/A
Recruiting	`NCT06360796` - Study of Pharmacokinetics and Metabolism on [(14)C]ADC189	Phase 1
Recruiting	`NCT02005003` - Cognitive and Metabolic Effects of a Probiotic Supplement	N/A
Completed	`NCT03146728` - Finding the Optimal Voluntary Exercise Parameters for Those Living With Quadriplegia	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.